Jinyu Bio-Technology Co Current Assets
The Current Assets of Jinyu Bio-Technology Co (600201.SS) as of Oct 27, 2026 is 291.00 M CNY. In the previous year, Current Assets was 2.20 B CNY — a change of -86.79% (lower).
Get this data via API
Financial Data API
Current Assets
291.00 MCNY
YoY
-86.79%
Last updated:
The Jinyu Bio-Technology Co Current Assets history
3 Years
10 Years
25 Years
Max
| YEAR | Current Assets | YoY |
|---|---|---|
| 291.00 MCNY | -86.79% | |
| 2.20 BCNY | -27.21% | |
| 3.03 BCNY | +8.28% | |
| 2.80 BCNY | -10.30% | |
| 3.12 BCNY | -3.33% | |
| 3.22 BCNY | +17.80% | |
| 2.74 BCNY | -28.09% | |
| 3.81 BCNY | -7.62% | |
| 4.12 BCNY | +27.90% | |
| 3.22 BCNY | +105.41% | |
| 1.57 BCNY | +13.17% | |
| 1.39 BCNY | +9.99% | |
| 1.26 BCNY | -12.10% | |
| 1.43 BCNY | +3.49% | |
| 1.38 BCNY | +8.84% | |
| 1.27 BCNY | +8.81% | |
| 1.17 BCNY | +26.01% | |
| 927.77 MCNY | -6.04% | |
| 987.45 MCNY | +59.43% | |
| 619.38 MCNY | -11.13% | |
| 696.92 MCNY | +9.15% | |
| 638.48 MCNY | -9.98% | |
| 709.23 MCNY | +32.71% | |
| 534.44 MCNY | +7.04% | |
| 499.27 MCNY | +34.33% | |
| 371.68 MCNY | -12.98% | |
| 427.12 MCNY | -18.34% | |
| 523.08 MCNY | +231.77% | |
| 157.66 MCNY | -3.15% | |
| 162.78 MCNY | +28.89% | |
| 126.30 MCNY | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Jinyu Bio-Technology Co Stock analysis
Frequently Asked Questions about Jinyu Bio-Technology Co stock
Current Assets of Jinyu Bio-Technology Co is 291.00 M CNY in 2025.
Current Assets of Jinyu Bio-Technology Co changed from 2.20 B CNY to 291.00 M CNY, representing a -86.79% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Current Assets Jinyu Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.
Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.
Current Assets's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Jinyu Bio-Technology Co historically and in real time.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Balance Sheet — Jinyu Bio-Technology Co
All Key Metrics — Jinyu Bio-Technology Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth